pretargeting

You have access
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer
Caroline Rousseau, David M. Goldenberg, Mathilde Colombié, Jean-Charles Sébille, Philippe Meingan, Ludovic Ferrer, Pierre Baumgartner, Evelyne Cerato, Damien Masson, Mario Campone, Aurore Rauscher, Vincent Fleury, Catherine Labbe, Alain Faivre Chauvet, Jean-Sebastien Fresnel, Claire Toquet, Jacques Barbet, Robert M. Sharkey, Loic Campion and Françoise Kraeber-Bodéré

Journal of Nuclear Medicine August 1, 2020, 61 (8) 1205-1211; DOI: https://doi.org/10.2967/jnumed.119.236000
Open Access
Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors
Patrícia M.R. Pereira, Komal Mandleywala, Ashwin Ragupathi, Lukas M. Carter, Jeroen A.C.M. Goos, Yelena Y. Janjigian and Jason S. Lewis

Journal of Nuclear Medicine November 1, 2019, 60 (11) 1569-1578; DOI: https://doi.org/10.2967/jnumed.119.225813
Open Access
Tumor Imaging Using Radiolabeled Matrix Metalloproteinase–Activated Anthrax Proteins
Mary-Ann Elvina Xavier, Shihui Liu, Thomas H. Bugge, Julia Baguña Torres, Michael Mosley, Samantha L. Hopkins, Phillip D. Allen, Georgina Berridge, Iolanda Vendrell, Roman Fischer, Veerle Kersemans, Sean Smart, Stephen H. Leppla and Bart Cornelissen

Journal of Nuclear Medicine October 1, 2019, 60 (10) 1474-1482; DOI: https://doi.org/10.2967/jnumed.119.226423
You have access
Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid–Mediated Pretargeting: In Vivo Proof of Principle
Kristina Westerlund, Mohamed Altai, Bogdan Mitran, Mark Konijnenberg, Maryam Oroujeni, Christina Atterby, Marion de Jong, Anna Orlova, Johanna Mattsson, Patrick Micke, Amelie Eriksson Karlström and Vladimir Tolmachev

Journal of Nuclear Medicine July 1, 2018, 59 (7) 1092-1098; DOI: https://doi.org/10.2967/jnumed.118.208348
You have access
Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer
Sarah M. Cheal, Edward K. Fung, Mitesh Patel, Hong Xu, Hong-fen Guo, Pat B. Zanzonico, Sebastien Monette, K. Dane Wittrup, Nai-Kong V. Cheung and Steven M. Larson

Journal of Nuclear Medicine November 1, 2017, 58 (11) 1735-1742; DOI: https://doi.org/10.2967/jnumed.117.193250
You have access
Pretargeted Imaging and Therapy
Mohamed Altai, Rosemery Membreno, Brendon Cook, Vladimir Tolmachev and Brian M. Zeglis

Journal of Nuclear Medicine October 1, 2017, 58 (10) 1553-1559; DOI: https://doi.org/10.2967/jnumed.117.189944
You have access
α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen–Expressing Human Colon Cancer Xenografts
Sandra Heskamp, Reinier Hernandez, Janneke D.M. Molkenboer-Kuenen, Markus Essler, Frank Bruchertseifer, Alfred Morgenstern, Erik J. Steenbergen, Weibo Cai, Christof Seidl, William J. McBride, David M. Goldenberg and Otto C. Boerman

Journal of Nuclear Medicine June 1, 2017, 58 (6) 926-933; DOI: https://doi.org/10.2967/jnumed.116.187021
You have access
Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and ⁶⁸Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial
Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Aurore Rauscher, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere

Journal of Nuclear Medicine October 1, 2016, 57 (10) 1505-1511; DOI: https://doi.org/10.2967/jnumed.116.172221
You have access
Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses
Jacob L. Houghton, Brian M. Zeglis, Dalya Abdel-Atti, Ritsuko Sawada, Wolfgang W. Scholz and Jason S. Lewis

Journal of Nuclear Medicine March 1, 2016, 57 (3) 453-459; DOI: https://doi.org/10.2967/jnumed.115.163824
You have access
Diabody Pretargeting with Click Chemistry In Vivo
Sander M.J. van Duijnhoven, Raffaella Rossin, Sandra M. van den Bosch, Michael P. Wheatcroft, Peter J. Hudson and Marc S. Robillard

Journal of Nuclear Medicine September 1, 2015, 56 (9) 1422-1428; DOI: https://doi.org/10.2967/jnumed.115.159145

Main menu

User menu

Search

pretargeting

Pages